Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Nefopam/Paracetamol FDC vs Components in Healthy Volunteers
NCT05129137Phase 1Completed
- Sponsor
- Unither Pharmaceuticals
- Start
- Nov 2021
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of nefopam and acetaminophen in pain (4 arms), sponsored by Unither Pharmaceuticals. Primary endpoints: Nefopam Pharmacokinetic Profiles at 48 hours and Paracetamol Pharmacokinetic Profiles at 48 hours. Started Nov 2021; status: completed.
02
Drugs
nefopamacetaminophen
03
Conditions
pain
Beyond the preview
Go deeper on NCT05129137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05129137.